Precise interpretation and prioritization of sequence variants with Onkopus for supporting molecular tumor boards

Nadine Sina Kurz,Kevin Kornrumpf,Tim Tucholski,Klara Drofenik,Alexander König,Tim Beißbarth,Jürgen Dönitz

DOI: https://doi.org/10.1101/2024.09.24.24314298

2024-09-25

Abstract:One of the major challenges in precision medicine is the identification of pathogenic, actionable variants and the selection of personalized treatments. We present Onkopus, a variant interpretation framework, based on a modular architecture, for interpreting and prioritizing genetic alterations in cancer patients. We show that aggregation and harmonization of clinical databases, coupled with querying of these databases to varying associated biomarkers, can increase the number of identified therapeutic options. We present a protein analysis of mutated sites and show that protein characteristics can provide potential indicators for the functional impairment of variants of unknown significance. Variant interpretation systems like Onkopus have the potential to significantly enhance the performance of personalized treatments, as they reduce the time required for variant interpretation and manual evaluation of personalized treatments, while maintaining reproducibility and traceability. We provide a free public instance of Onkopus at https://mtb.bioinf.med.uni-goettingen.de/onkopus.

What problem does this paper attempt to address?

The main problem this paper attempts to address is the identification of genetic variations and the selection of personalized treatment plans in precision medicine. Specifically, the paper introduces Onkopus, a modular architecture-based variant interpretation framework, used to interpret and prioritize genetic variations in cancer patients. By integrating and unifying clinical databases and querying information about different relevant biomarkers within these databases, the number of identified treatment options can be increased. Additionally, the paper demonstrates a method for protein analysis of mutation sites and shows that protein properties can serve as potential indicators of functional damage in variants of unknown significance (VUS). A variant interpretation system like Onkopus has the potential to significantly improve the effectiveness of personalized treatment, as it can reduce the time required for variant interpretation and the manual evaluation time for personalized treatment plans, while maintaining the reproducibility and traceability of the results. The paper also provides a free public instance of Onkopus for users to access and use.